Molecular Tumor Board treatment predictions on rare EGFR exon 20 mutations

被引：0
|
作者：
van der Wekken, Anthonie J.
Groves, Matthew R.
ter Elst, Arja
't Hart, Nils A.
Hijmering-Kappelle, Lucie B.
Hiltermann, Thijo J.
van den Berg, Anke
Timens, Wim
Schuuring, Ed
Groen, Harry J.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2718
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2718
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results
    Wang, Mengzhao
    Fan, Yun
    Sun, Meili
    Wang, Yongsheng
    Zhao, Yanqiu
    Jin, Bo
    Hu, Ying
    Han, Zhigang
    Song, Xia
    Liu, Anwen
    Tang, Kejing
    Ding Cuimin
    Liang, Li
    Wu, Lin
    Gao, Junzhen
    Wang, Jianghong
    Cheng, Ying
    Zhou, Jianying
    He, Yong
    Zheng, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations
    Xu, Yan
    Yang, James Chih-Hsin
    Chiu, Chao-Hua
    Hsu, Ping-Chih
    Mitchell, Paul
    Chang, Chia Lun
    John, Tom
    Bazhenova, Lyudmila
    Kim, Tae Min
    Yip, Ching Wan
    Wang, Mengzhao
    Janne, Pasi A.
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations
    Yang, J. C-H.
    Wang, M.
    Chiu, C-H.
    Hsu, P-C.
    Mitchell, P.
    Chang, C. L.
    Kim, T. M.
    John, T.
    Greillier, L.
    Bazhenova, L.
    Carcereny, E.
    Spira, A. I.
    Shim, B.
    Lee, K. H.
    Cobo Dols, M.
    Ghiringhelli, F.
    Yip, C. W.
    Xiong, J.
    Janne, P. A.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [24] Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations
    Bazhenova, Lyudmila
    Minchom, Anna
    Viteri, Santiago
    Bauml, Joshua M.
    Ou, Sai-Hong Ignatius
    Gadgeel, Shirish M.
    Manuel Trigo, Jose
    Backenroth, Daniel
    Li, Tracy
    Londhe, Anil
    Mahadevia, Parthiv
    Girard, Nicolas
    LUNG CANCER, 2021, 162 : 154 - 161
  • [25] Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations
    Lund-Iversen, Marius
    Kleinberg, Lilach
    Fjellbirkeland, Lars
    Helland, Aslaug
    Brustugun, Odd Terje
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1471 - 1473
  • [26] EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy
    Park, Jason Y.
    Cohen, Cynthia
    Lopez, Dania
    Ramos, Erica
    Wagenfuehr, Jennifer
    Rakheja, Dinesh
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1713 - 1718
  • [27] EGFR mutations in sinonasal squamous neoplasms: Novel hotspot for exon 20 insertions
    Srivastava, Kirti
    Kaur, Kavneet
    Verma, Hitesh
    Jain, Deepali
    Thakar, Alok
    Kakkar, Aanchal
    VIRCHOWS ARCHIV, 2025,
  • [28] Resistance mechanisms to mobocertinib in treating NSCLC with EGFR exon 20 insertion mutations
    Le, Xiuning
    Nilsson, Monique
    Chatterjee, Sampurna
    Su, Zhenqiang
    He, Junqin
    Udagawa, Hibiki
    Yu, Xiaoxing
    Poteete, Alissa
    Huang, Qian
    Heymach, John V.
    Vincent, Sylvie
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [29] Treatment response and outcomes of non-small-cell lung cancer with EGFR gene mutations in exon 20
    Miyanaga, Akihiko
    Akagi, Kiwamu
    Takeuchi, Susumu
    Toyokawa, Masaru
    Sudo, Junko
    Kurimoto, Futoshi
    Yoshino, Naoyuki
    Mikami, Iwao
    Akiyama, Hirohiko
    Sakai, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S920 - S920
  • [30] Capturing the Patient Experience for the Treatment of EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer
    Bell, J.
    Roberts, L.
    Jean-Baptiste, M.
    Revicki, D.
    Salvatore, G.
    Li, S.
    Galaznik, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S991 - S992
12345